664 related articles for article (PubMed ID: 27326409)
1. The role of microRNAs in bladder cancer.
Enokida H; Yoshino H; Matsushita R; Nakagawa M
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S60-76. PubMed ID: 27326409
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of microRNAs in bladder cancer.
Yoshino H; Seki N; Itesako T; Chiyomaru T; Nakagawa M; Enokida H
Nat Rev Urol; 2013 Jul; 10(7):396-404. PubMed ID: 23712207
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs: Key Players in Bladder Cancer.
Li Q; Wang H; Peng H; Huang Q; Huyan T; Huang Q; Yang H; Shi J
Mol Diagn Ther; 2019 Oct; 23(5):579-601. PubMed ID: 31325035
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly expressed microRNAs in the context of bladder tumorigenesis.
Lee JY; Ryu DS; Kim WJ; Kim SJ
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S52-9. PubMed ID: 27326408
[TBL] [Abstract][Full Text] [Related]
5. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
Braicu C; Buiga R; Cojocneanu R; Buse M; Raduly L; Pop LA; Chira S; Budisan L; Jurj A; Ciocan C; Magdo L; Irimie A; Dobrota F; Petrut B; Berindan-Neagoe I
J Exp Clin Cancer Res; 2019 Oct; 38(1):433. PubMed ID: 31665050
[TBL] [Abstract][Full Text] [Related]
6. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of microRNAs associated with UCA1 in bladder cancer cells.
Xie X; Pan J; Wei L; Wu S; Hou H; Li X; Chen W
Int J Oncol; 2016 Apr; 48(4):1617-27. PubMed ID: 26820254
[TBL] [Abstract][Full Text] [Related]
8. microRNA expression profiles as decision-making biomarkers in the management of bladder cancer.
Amir S; Mabjeesh NJ
Histol Histopathol; 2017 Feb; 32(2):107-119. PubMed ID: 27586262
[TBL] [Abstract][Full Text] [Related]
9. Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice.
Blanca A; Cheng L; Montironi R; Moch H; Massari F; Fiorentino M; Raspollini MR; Scarpelli M; Lopez-Beltran A
Curr Drug Metab; 2017 Oct; 18(8):712-722. PubMed ID: 28524002
[TBL] [Abstract][Full Text] [Related]
10. Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.
Kurozumi A; Goto Y; Okato A; Ichikawa T; Seki N
J Hum Genet; 2017 Jan; 62(1):49-56. PubMed ID: 27357429
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids.
Matullo G; Naccarati A; Pardini B
Int J Cancer; 2016 May; 138(10):2334-45. PubMed ID: 26489968
[TBL] [Abstract][Full Text] [Related]
12. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
[TBL] [Abstract][Full Text] [Related]
14. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
[TBL] [Abstract][Full Text] [Related]
15. Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors.
Strømme O; Heck KA; Brede G; Lindholm HT; Otterlei M; Arum CJ
Curr Issues Mol Biol; 2021 Jun; 43(1):286-300. PubMed ID: 34199766
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
17. Plasma microRNA profiles for bladder cancer detection.
Adam L; Wszolek MF; Liu CG; Jing W; Diao L; Zien A; Zhang JD; Jackson D; Dinney CP
Urol Oncol; 2013 Nov; 31(8):1701-8. PubMed ID: 22863868
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy.
Liu W; Qi L; Lv H; Zu X; Chen M; Wang J; Liu L; Zeng F; Li Y
BMC Cancer; 2015 Mar; 15():92. PubMed ID: 25884322
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.
Stempor PA; Avni D; Leibowitz R; Sidi Y; Stępień M; Dzieciątkowski T; Dobosz P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]